Following the release of the 3rd quarter results, analyst Russell Stanley reiterated his buy rating and 12 month target of $1.25, a premium of 131% to the $0.54 price on November 18th, the day the report was issued. Gemini reported revenue of $33.7 million, EBITDA of $2.1 million and diluted earnings per share of $0.02 per share.